Editorial comment on: Weekly docetaxel and prednisolone versus prednisolone alone in androgen-independent prostate cancer: a randomized phase II study
- PMID: 17306444
- DOI: 10.1016/j.eururo.2007.01.105
Editorial comment on: Weekly docetaxel and prednisolone versus prednisolone alone in androgen-independent prostate cancer: a randomized phase II study
Comment on
-
Weekly docetaxel and prednisolone versus prednisolone alone in androgen-independent prostate cancer: a randomized phase II study.Eur Urol. 2007 Dec;52(6):1691-8. doi: 10.1016/j.eururo.2007.01.104. Epub 2007 Feb 8. Eur Urol. 2007. PMID: 17306441 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical